17:31 , Aug 3, 2018 |  BC Week In Review  |  Financial News

DotBio launches with $2.3M seed round

Newco DotBio Pte. Ltd. (Singapore) launched with a $2.3 million seed round led by Futec Biomedical Investments Ltd. of HeungKong Group Ltd. Other undisclosed investors participated in the round. DotBio spun out of Nanyang Technological...
19:29 , Aug 1, 2018 |  BC Innovations  |  Emerging Company Profile

Connecting the DotBodies

Cancer play DotBio Pte. Ltd. launched this week with a screening platform to discover and develop products based on humanized domain antibodies that could be more stable and easier to manufacture than other domain antibodies....
12:00 , Jul 30, 2018 |  BC Extra  |  Financial News

DotBio launches with $2.3M seed round

Newco DotBio Pte. Ltd. (Singapore) launched with a $2.3 million seed round led by Futec Biomedical Investments Ltd. of HeungKong Group Ltd. Other undisclosed investors participated in the round. DotBio spun out of Nanyang Technological...
07:00 , Sep 1, 2014 |  BC Week In Review  |  Financial News

Armetheon completes venture financing

Armetheon Inc. , Menlo Park, Calif.   Business: Cardiovascular, Infectious   Date completed: 2014-08-28   Type: Venture financing   Raised: $7 million   Investors: AshHill Biomedical Investments; Hercules Bioventures; Atheneos Capital; individual investor  ...
07:00 , Mar 15, 2010 |  BioCentury  |  Finance

Ebb & Flow

Israeli life sciences investment group Clal Biotechnology Industries has acquired another Israeli VC, Biomedical Investments, for NIS84 million ($23 million), of which $7.5 million was cash, along with 3 million shares and 1.25 million warrants....
01:42 , Oct 21, 2008 |  BC Extra  |  Financial News

S*BIO raises $26 million

S*BIO (Singapore) raised US$26 million in a series B round co-led by existing investor Bio*One Capital and new investor Aravis Venture. New investors Lacuna Apo BioTech Fund, which is advised by Adamant Biomedical Investments, and...
07:00 , Aug 18, 2008 |  BC Week In Review  |  Company News

Serentis board of directors update

Serentis Ltd. , Cambridge, U.K.   Business: Dermatology, Other   Appointed: Bill Blair, CEO of Adamant Biomedical Investments Ltd.’s Adamant Ventures subsidiary  ...
07:00 , Jun 2, 2008 |  BioCentury  |  Finance

Ebb & Flow

Southern exposure By Stacy Lawrence & Mike Ward With only one Phase I compound left in its pipeline, cancer company Sonus (NASDAQ:SNUS) last week announced a 50-50 reverse merger with private Canadian cancer company OncoGenex...
07:00 , Apr 21, 2008 |  BioCentury  |  Finance

Ebb & Flow

Less than a month after completing its acquisition of cancer and infectious disease company Celldex in a stock deal for about $75 million, Avant (NASDAQ:AVAN) has received cash covering more than half of the purchase...
07:00 , Apr 7, 2008 |  BioCentury  |  Finance

2Q Financial Markets Preview: Longing for normalcy

With stock market volatility expected to continue this quarter, investors say they will continue the flight to quality that began at the end of last year. The few buysiders who are not sitting on the...